PRKCD and neuroblastoma: Since rottlerin has been described as a factor having both PKCδ-dependent and -independent effects [43], [44], we were prompted to apply targeted PKCδ mRNA silencing to clarify the direct role of PKCδ in the sensitization of neuroblastoma cells to the employed drugs.